{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:16:33Z","timestamp":1793909793748,"version":"4.8.0"},"reference-count":245,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    The dissemination of antibiotic resistance in\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    poses a significant threat to public health worldwide. This review provides a comprehensive update on the diverse mechanisms employed by\n                    <jats:italic>E. coli<\/jats:italic>\n                    in developing resistance to antibiotics. We primarily focus on pathotypes of\n                    <jats:italic>E. coli<\/jats:italic>\n                    (e.g., uropathogenic\n                    <jats:italic>E. coli<\/jats:italic>\n                    ) and investigate the genetic determinants and molecular pathways that confer resistance, shedding light on both well-characterized and recently discovered mechanisms. The most prevalent mechanism continues to be the acquisition of resistance genes through horizontal gene transfer, facilitated by mobile genetic elements such as plasmids and transposons. We discuss the role of extended-spectrum\n                    <jats:italic>\u03b2<\/jats:italic>\n                    -lactamases (ESBLs) and carbapenemases in conferring resistance to\n                    <jats:italic>\u03b2<\/jats:italic>\n                    -lactam antibiotics, which remain vital in clinical practice. The review covers the key resistant mechanisms, including: 1) Efflux pumps and porin mutations that mediate resistance to a broad spectrum of antibiotics, including fluoroquinolones and aminoglycosides; 2) adaptive strategies employed by\n                    <jats:italic>E. coli<\/jats:italic>\n                    , including biofilm formation, persister cell formation, and the activation of stress response systems, to withstand antibiotic pressure; and 3) the role of regulatory systems in coordinating resistance mechanisms, providing insights into potential targets for therapeutic interventions. Understanding the intricate network of antibiotic resistance mechanisms in\n                    <jats:italic>E. coli<\/jats:italic>\n                    is crucial for the development of effective strategies to combat this growing public health crisis. By clarifying these mechanisms, we aim to pave the way for the design of innovative therapeutic approaches and the implementation of prudent antibiotic stewardship practices to preserve the efficacy of current antibiotics and ensure a sustainable future for healthcare.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2024.1387497","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T07:40:47Z","timestamp":1712216447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":210,"title":["A review of the mechanisms that confer antibiotic resistance in pathotypes of E. coli"],"prefix":"10.3389","volume":"14","author":[{"given":"Sina","family":"Nasrollahian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay P.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Halaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1016\/j.sjbs.2021.03.047","article-title":"Antimicrobial resistance patterns among different Escherichia coli isolates in the Kingdom of Saudi Arabia","volume":"28","author":"Aabed","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5604\/17331331.1234990","article-title":"Expression of the Fluoroquinolones Efflux Pump Genes acrA and mdfA in Urinary Escherichia coli Isolates","volume":"66","author":"Abdelhamid","year":"2017","journal-title":"Pol. J. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12879-023-08449-9","article-title":"High incidence of fosfomycin-resistant uropathogenic E. coli among children","volume":"23","author":"Abdelraheem","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"B4","first-page":"116","article-title":"Isolation, Identification and antibiotic resistance profile distribution of clinical E. coli in Iraqi patients","volume":"8","author":"AbdulHameed","year":"2022","journal-title":"Eurasian Medical Research Periodical."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/sajrm\/2019\/v4i330108","article-title":"Phenotypic detection of extended spectrum beta-lactamase resistance of Escherichia coli from patients attending selected healthcare facilities in Nasarawa State, Nigeria","volume":"4","author":"Abimiku","year":"2019","journal-title":"South Asian J. Res. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11033-018-4254-0","article-title":"The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains","volume":"45","author":"Adamus-Bia\u0142ek","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4161\/mge.25204","article-title":"First report on class 1 integrons and Trimethoprim-resistance genes from dfrA group in uropathogenic E. coli (UPEC) from the Aleppo area in Syria","volume":"3","author":"Al-Assil","year":"2013","journal-title":"Mobile Genet. elements."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/jac\/dky042","article-title":"Role of bacterial efflux pumps in biofilm formation","volume":"73","author":"Alav","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/biology11091328","article-title":"Drug efflux pump inhibitors: A promising approach to counter multidrug resistance in gram-negative pathogens by targeting AcrB protein from AcrAB-TolC multidrug efflux pump from Escherichia coli","volume":"11","author":"Alenazy","year":"2022","journal-title":"Biology."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac035","article-title":"Evaluation of in vitro activity of ceftolozane\/tazobactam and comparators against recent clinical bacterial isolates, and genomics of Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli isolates that demonstrated resistance to ceftolozane\/tazobactam: data from Kuwait and Oman","volume":"4","author":"Alfouzan","year":"2022","journal-title":"JAC-Antimicrobial Resistance"},{"key":"B11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.47750\/jptcp.2023.30.05.047","article-title":"The emergence of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) in Iraqi clinical isolates of Escherichia coli","volume":"30","author":"Al-Hasani","year":"2023","journal-title":"J. Population Ther. Clin. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.24996\/ijs.2022.63.6.7","article-title":"Detection of efflux pumps gene and\u00a0relation with antibiotics resistance in Uropathogenic Escherichia coli (UPEC) isolated from patients with cystitis","volume":"63","author":"Ali","year":"2022","journal-title":"Iraqi J. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jiph.2023.05.026","article-title":"Reduction of biofilm formation of Escherichia coli by targeting quorum sensing and adhesion genes using the CRISPR\/Cas9-HDR approach, and its clinical application on urinary catheter","volume":"16","author":"Alshammari","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1556\/030.2022.01782","article-title":"Activity of meropenem-vaborbactam against different beta-lactamase producing Klebsiella pneumoniae and Escherichia coli isolates in Iran","volume":"69","author":"Amereh","year":"2022","journal-title":"Acta Microbiologica Immunologica Hungarica."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/ijerph120201487","article-title":"Multidrug Efflux Pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus Bacterial Food Pathogens","volume":"12","author":"Andersen","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/antibiotics12071117","article-title":"Mobile colistin resistance (mcr) gene-containing organisms in poultry sector in low- and middle-income countries: epidemiology, characteristics, and one health control strategies","volume":"12","author":"Anyanwu","year":"2023","journal-title":"Antibiotics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/jac\/40.3.393","article-title":"Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicenter survey","volume":"40","author":"Arca","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.2147\/IDR.S284751","article-title":"Plasmid-mediated AmpC \u03b2-lactamase CITM and DHAM genes among gram-negative clinical isolates","volume":"13","author":"Aryal","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"B19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.34172\/ajcmi.2019.09","article-title":"Prevalence of multidrug-resistant, extensively drug-resistant and pandrug-resistant uropathogens isolated from urinaryTract infection cases in Dhaka, Bangladesh","volume":"6","author":"Asma","year":"2019","journal-title":"Avicenna J. Clin. Microbiol. Infect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42522-023-00079-0","article-title":"Quinolone-resistant Escherichia coli at the interface between humans, poultry and their shared environment- a potential public health risk","volume":"5","author":"Aworh","year":"2023","journal-title":"One Health Outlook."},{"key":"B21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/microbiol.2021013","article-title":"Plasmid-mediated quinolone resistance genes transfer among enteric bacteria isolated from human and animal sources","volume":"7","author":"Ayobola","year":"2021","journal-title":"AIMS Microbiol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.609840","article-title":"Colistin resistance among multiple sequence types of Klebsiella pneumoniae is associated with diverse resistance mechanisms: A report from India","volume":"12","author":"Azam","year":"2021","journal-title":"Front. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jgar.2018.11.003","article-title":"Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran","volume":"17","author":"Azargun","year":"2019","journal-title":"J. Glob Antimicrob. Resist."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40348-022-00134-2","article-title":"Evaluation of phenotypic and genotypic patterns of aminoglycoside resistance in the Gram-negative bacteria isolates collected from pediatric and general hospitals","volume":"9","author":"Azimi","year":"2022","journal-title":"Mol. Cell Pediatr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"115652","DOI":"10.1016\/j.diagmicrobio.2022.115652","article-title":"In vitro activity of Ceftazidime-Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019","volume":"103","author":"Bakthavatchalam","year":"2022","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1021\/acs.oprd.6b00268","article-title":"Development of a manufacturing route to avibactam, a \u03b2-lactamase inhibitor","volume":"20","author":"Ball","year":"2016","journal-title":"Organic Process Res. Dev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/microorganisms10061103","article-title":"Clinical Escherichia coli: from biofilm formation to new antibiofilm strategies","volume":"10","author":"Ball\u00e9n","year":"2022","journal-title":"Microorganisms"},{"key":"B28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomized, open-label, multicenter, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/pathogens11060659","article-title":"Worldwide Prevalence of mcr-mediated Colistin-Resistance Escherichia coli in Isolates of Clinical Samples, Healthy Humans, and Livestock-A Systematic Review and Meta-Analysis","volume":"11","author":"Bastidas-Caldes","year":"2022","journal-title":"Pathogens"},{"key":"B30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jgar.2018.03.009","article-title":"Incidence and risk of co-transmission of plasmid-mediated quinolone resistance and extended-spectrum \u03b2-lactamase genes in fluoroquinolone-resistant uropathogenic Escherichia coli: a first study from Kolkata, India","volume":"14","author":"Basu","year":"2018","journal-title":"J. Glob Antimicrob. Resist."},{"key":"B31","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/antibiotics10060652","article-title":"Cefiderocol-based combination therapy for \"Difficult-to-treat\" Gram-negative severe infections: real-life case series and future perspectives","volume":"10","author":"Bavaro","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.bbamem.2007.08.015","article-title":"Small multidrug resistance proteins: a multidrug transporter family that continues to grow","volume":"1778","author":"Bay","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"B33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2148-9-140","article-title":"Diversity and evolution of the small multidrug resistance protein family","volume":"9","author":"Bay","year":"2009","journal-title":"BMC Evol. Biol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9781119593522.ch1","article-title":"Molecular mechanisms of antibiotic resistance \u2013 part I","volume-title":"Bacterial Resistance to Antibiotics \u2013 From Molecules to Man","author":"Baylay","year":"2019"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02400-18","article-title":"Respiratory heterogeneity shapes biofilm formation and host colonization in uropathogenic Escherichia coli","volume":"10","author":"Beebout","year":"2019","journal-title":"mBio"},{"key":"B36","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1185\/03007995.2015.1018989","article-title":"Colistin, mechanisms and prevalence of resistance","volume":"31","author":"Bialvaei","year":"2015","journal-title":"Curr. Med. Res. Opinion."},{"key":"B37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1089\/mdr.2014.0036","article-title":"Blocking peptidoglycan recycling in Pseudomonas aeruginosa attenuates intrinsic resistance to fosfomycin","volume":"20","author":"Borisova","year":"2014","journal-title":"Microb. Drug Resist."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1453.e1451","DOI":"10.1016\/j.cmi.2023.07.017","article-title":"Rapid detection of imipenem\/relebactam susceptibility\/resistance in Enterobacterales","volume":"29","author":"Bouvier","year":"2023","journal-title":"Clin. Microbiol. Infect"},{"key":"B39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.14740\/jocmr4764","article-title":"Carbapenemase inhibitors: updates on developments in 2021","volume":"14","author":"Bou Zerdan","year":"2022","journal-title":"J. Clin. Med. Res."},{"key":"B40","first-page":"ofaa054","article-title":"Evaluation of renal safety between imipenem\/relebactam and colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 study","volume-title":"Open Forum Infect Dis.","author":"Brown","year":"2020"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/microorganisms10081684","article-title":"Evidence of community-wide spread of multi-drug resistant Escherichia coli in young children in Lusaka and Ndola districts, Zambia","volume":"10","author":"Bumbangi","year":"2022","journal-title":"Microorganisms"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e00047-19","DOI":"10.1128\/CMR.00047-19","article-title":"Epidemiology of \u03b2-lactamase-producing pathogens","volume":"33","author":"Bush","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1017\/S0950268816002879","article-title":"High prevalence of fosfomycin resistance gene fosA3 in blaCTX-M-harboring Escherichia coli from urine in a Chinese tertiary hospital during 2010\u20132014","volume":"145","author":"Cao","year":"2017","journal-title":"Epidemiol. Infect."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1089\/mdr.2020.0387","article-title":"Plasmid-encoded AmpC and extended-spectrum beta-lactamases in multidrug-resistant Escherichia coli isolated from piglets in Portugal","volume":"27","author":"Cardoso","year":"2021","journal-title":"Microb. Drug Resist."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1093\/jac\/dkz354","article-title":"Activity of imipenem\/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance","volume":"74","author":"Carpenter","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1093\/jac\/dkad201","article-title":"Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK","volume":"78","author":"Carter","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"106815","DOI":"10.1016\/j.ijantimicag.2023.106815","article-title":"In vitro activity of imipenem\/relebactam, meropenem\/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020","volume":"61","author":"Chang","year":"2023","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1093\/jac\/dkv267","article-title":"New pharmacokinetic\/pharmacodynamic studies of systemically administered colistin againstPseudomonas aeruginosaandAcinetobacter baumanniiin mouse thigh and lung infection models: smaller response in lung infection","volume":"70","author":"Cheah","year":"2015","journal-title":"J. Antimicrob. Chemother"},{"key":"B49","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12866-019-1589-1","article-title":"AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli","volume":"19","author":"Chetri","year":"2019","journal-title":"BMC Microbiol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00953","article-title":"Distinct roles of outer membrane Porins in antibiotic resistance and membrane integrity in Escherichia coli","volume":"10","author":"Choi","year":"2019","journal-title":"Front. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1178636119889629","DOI":"10.1177\/1178636119889629","article-title":"Identification of AcrAB-tolC efflux pump genes and detection of mutation in efflux repressor AcrR from omeprazole responsive multidrug-resistant Escherichia coli isolates causing urinary tract infections","volume":"12","author":"Chowdhury","year":"2019","journal-title":"Microbiol. Insights"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1021\/acsinfecdis.2c00315","article-title":"\u03b2-lactamase-mediated fragmentation: historical perspectives and recent advances in diagnostics, imaging, and antibacterial design","volume":"8","author":"Cole","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.563944","article-title":"(p)ppGpp metabolism and antimicrobial resistance in bacterial pathogens","volume":"11","author":"Das","year":"2020","journal-title":"Front. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1089\/mdr.2018.0240","article-title":"Distribution of clinical NDM-1-producing gram-negative bacteria in Brazil","volume":"25","author":"da Silva","year":"2019","journal-title":"Microbial Drug Resistance."},{"key":"B55","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1186\/s13104-019-4825-8","article-title":"Identification phenotypic and genotypic characterization of biofilm formation in Escherichia coli isolated from urinary tract infections and their antibiotics resistance","volume":"12","author":"Davari Abad","year":"2019","journal-title":"BMC Res. Notes."},{"key":"B56","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/antibiotics12060965","article-title":"Antimicrobial resistance: two-component regulatory systems and multidrug efflux pumps","volume":"12","author":"De Gaetano","year":"2023","journal-title":"Antibiotics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"106361","DOI":"10.1016\/j.ijantimicag.2021.106361","article-title":"Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study","volume":"58","author":"Delory","year":"2021","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mib.2019.06.004","article-title":"The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: the complexity of clones and plasmids","volume":"51","author":"Dunn","year":"2019","journal-title":"Curr. Opin. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1289683","article-title":"Comparative study of virulence potential, phylogenetic origin, CRISPR-Cas regions and drug resistance of Escherichia coli isolates from urine and other clinical materials","volume":"14","author":"Dziuba","year":"2023","journal-title":"Front. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"7178","DOI":"10.1128\/AAC.01806-16","article-title":"The expression of antibiotic resistance methyltransferase correlates with mRNA stability independently of ribosome stalling","volume":"60","author":"Dzyubak","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/emboj\/18.4.822","article-title":"A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA","volume":"18","author":"Edgar","year":"1999","journal-title":"EMBO J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.32607\/20758251-2018-10-4-33-48","article-title":"Bacterial enzymes and antibiotic resistance","volume":"10","author":"Egorov","year":"2018","journal-title":"Acta Naturae."},{"key":"B63","doi-asserted-by":"publisher","first-page":"8050432","DOI":"10.1155\/2017\/8050432","article-title":"Molecular Identification of Aminoglycoside-Modifying Enzymes and Plasmid-Mediated Quinolone Resistance Genes among Klebsiella pneumoniae Clinical Isolates Recovered from Egyptian Patients","volume":"2017","author":"El-Badawy","year":"2017","journal-title":"Int. J. Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/1060028020929988","article-title":"Cefiderocol: A siderophore cephalosporin","volume":"54","author":"El-Lababidi","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.22207\/JPAM","article-title":"Effect of Carbonyl Cyanide M-chlorophenylhydrazone on Ciprofloxacin Resistance and Biofilm Formation in Hospital-acquired Uropathogenic Escherichia coli and Klebsiella pneumoniae","volume":"16","author":"El-Mahdy","year":"2022","journal-title":"J. Pure Appl. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","article-title":"Colistin and its role in the Era of antibiotic resistance: an extended review, (2000-2019)","volume":"9","author":"El-Sayed Ahmed","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.jmb.2018.07.026","article-title":"Functional amyloid and other protein fibers in the biofilm matrix","volume":"430","author":"Erskine","year":"2018","journal-title":"J. Mol. Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"228","DOI":"10.52547\/qums.15.3.210","article-title":"Detecting efflux pumps genes in the fluoroquinolones resistant and sensitive strains of Escherichia coli in patients with urinary tract infection in Qom, Iran","volume":"15","author":"Eshaghi","year":"2021","journal-title":"Qom Univ. Med. Sci. J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jgar.2023.09.003","article-title":"Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin","volume":"35","author":"Findlay","year":"2023","journal-title":"J. Global Antimicrobial Resistance"},{"key":"B70","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1473-3099(18)30279-2","article-title":"Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomized, open-label trial","volume":"18","author":"Fisher","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.1038\/nmicrobiol.2017.70","article-title":"Structure of the MacAB-TolC ABC-type tripartite multidrug efflux pump","volume":"2","author":"Fitzpatrick","year":"2017","journal-title":"Nat. Microbiol."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02261","article-title":"Double-serine fluoroquinolone resistance mutations advance major international clones and lineages of various multi-drug resistant bacteria","volume":"8","author":"Fuzi","year":"2017","journal-title":"Front. Microbiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/antibiotics11050628","article-title":"Resistance to ceftazidime\/avibactam, meropenem\/vaborbactam and imipenem\/relebactam in gram-negative MDR bacilli: molecular mechanisms and susceptibility testing","volume":"11","author":"Gaibani","year":"2022","journal-title":"Antibiotics"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/antibiotics11101383","article-title":"Emergence of fosfomycin resistance by plasmid-mediated fos genes in uropathogenic ESBL-producing E coli isolates Mexico","volume":"11","author":"Galindo-M\u00e9ndez","year":"2022","journal-title":"Antibiotics."},{"key":"B75","volume-title":"Genetic basis for in vivo piperacillin-tazobactam resistance","author":"Galvez-Benitez","year":"2023"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e01399","DOI":"10.1128\/aac.01399-21","article-title":"Exposure\u2013efficacy analyses support optimal dosing regimens of ceftolozane\/tazobactam in participants with hospital-acquired\/ventilator-associated bacterial pneumonia in ASPECT-NP","volume":"66","author":"Gao","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"B77","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18773\/austprescr.2019.002","article-title":"Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems","volume":"42","author":"Gardiner","year":"2019","journal-title":"Aust. Prescr."},{"key":"B78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/C5MD00344J","article-title":"Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives","volume":"7","author":"Garneau-Tsodikova","year":"2016","journal-title":"Medchemcomm"},{"key":"B79","doi-asserted-by":"publisher","first-page":"105412","DOI":"10.1016\/j.micpath.2022.105412","article-title":"A global systematic review and meta-analysis on correlation between biofilm producers and non-biofilm producers with antibiotic resistance in Uropathogenic Escherichiacoli","volume":"164","author":"Garousi","year":"2022","journal-title":"Microb. Pathog."},{"key":"B80","first-page":"33","article-title":"Urinary tract infections in older adults residing in long-term care facilities","volume":"20","author":"Genao","year":"2012","journal-title":"Ann. Longterm Care"},{"key":"B81","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.cmi.2015.05.022","article-title":"Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin","volume":"21","author":"Giske","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"B82","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1017\/ice.2019.42","article-title":"Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission","volume":"40","author":"Goodman","year":"2019","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025387","article-title":"Tetracycline antibiotics and resistance","volume":"6","author":"Grossman","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01854-22","article-title":"In vitro activity of new \u03b2-lactam-\u03b2-lactamase inhibitor combinations and comparators against clinical isolates of gram-negative bacilli: results from the China antimicrobial surveillance network (CHINET) in 2019","volume":"10","author":"Guo","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02161-21","article-title":"In Vitro Activity of Cefepime-Taniborbactam against Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa Isolates Recovered in Spain","volume":"66","author":"Hern\u00e1ndez-Garc\u00eda","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"B86","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/pathogens10010067","article-title":"Emergence of the new KPC-49 variant conferring an ESBL phenotype with resistance to ceftazidime-avibactam in the ST131-H30R1 Escherichia coli high-risk clone","volume":"10","author":"Hern\u00e1ndez-Garc\u00eda","year":"2021","journal-title":"Pathogens"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1099\/jmm.0.062653-0","article-title":"Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates","volume":"62","author":"Ho","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/jam.12099","article-title":"Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrug-resistant Escherichia coli from livestock and other animals","volume":"114","author":"Ho","year":"2013","journal-title":"J. Appl. Microbiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1128\/aac.02156-15","article-title":"Plasmid-mediated OqxAB is an important mechanism for nitrofurantoin resistance in Escherichia coli","volume":"60","author":"Ho","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.2147\/IDR.S315384","article-title":"In vitro Activity of Meropenem-Vaborbactam versus Other Antibiotics Against Carbapenem-Resistant Escherichia coli from Southeastern China","volume":"14","author":"Huang","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"B92","doi-asserted-by":"publisher","first-page":"001104","DOI":"10.1099\/mic.0.001104","article-title":"Colistin resistance in Escherichia coli confers protection of the cytoplasmic but not outer membrane from the polymyxin antibiotic","volume":"167","author":"Humphrey","year":"2021","journal-title":"Microbiol. (Reading)"},{"key":"B93","article-title":"Efflux Pumps among Urinary E. coli and K. pneumoniae Local Isolates in Hilla City, Iraq","volume-title":"The Global Antimicrobial Resistance Epidemic","author":"Hussein","year":"2022"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.21608\/ejhm.2023.291443","article-title":"Molecular detection of some efflux pumps genes in Escherichia coli isolated from patients with urinary tract infections in Baqubah City, Iraq","volume":"90","author":"Ibrahim","year":"2023","journal-title":"Egyptian J. Hosp. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1128\/microbiolspec.PLAS-0006-2013","article-title":"Plasmid-mediated quinolone resistance","volume":"2","author":"Jacoby","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009262","article-title":"Harder, better, faster, stronger: Colistin resistance mechanisms in Escherichia coli","volume":"17","author":"Janssen","year":"2021","journal-title":"PloS Genet."},{"key":"B97","doi-asserted-by":"publisher","first-page":"159497","DOI":"10.1016\/j.scitotenv.2022.159497","article-title":"Transmission of antibiotic resistance genes through mobile genetic elements in Acinetobacter baumannii and gene-transfer prevention","volume":"857","author":"Jeon","year":"2023","journal-title":"Sci. Total Environ."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01355","article-title":"Resistance Mutations in gyrA and parC are Common in Escherichia Communities of both Fluoroquinolone-Polluted and Uncontaminated Aquatic Environments","volume":"6","author":"Johnning","year":"2015","journal-title":"Front. Microbiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jgar.2020.12.017","article-title":"Activity of meropenem\/vaborbactam against international carbapenem-resistant Escherichia coli isolates in relation to clonal background, resistance genes, resistance to comparators and region","volume":"24","author":"Johnston","year":"2021","journal-title":"J. Global Antimicrobial Resistance."},{"key":"B100","doi-asserted-by":"publisher","first-page":"390","DOI":"10.24171\/j.phrp.2021.0272","article-title":"Prevalence of plasmid-mediated AmpC \u03b2-lactamases among uropathogenic Escherichia coli isolates in southwestern Iran","volume":"12","author":"Jomehzadeh","year":"2021","journal-title":"Osong Public Health Res. Perspect."},{"key":"B101","doi-asserted-by":"publisher","first-page":"101","DOI":"10.30466\/vrf.2019.96366.2309","article-title":"High incidence of multidrug resistance and class 1 and 2 integrons in Escherichia coli isolated from broiler chickens in South of Iran","volume":"12","author":"Kalantari","year":"2021","journal-title":"Vet. Res. Forum."},{"key":"B102","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2217\/fmb-2022-0097","article-title":"Klebsiella pneumoniae: an update on antibiotic resistance mechanisms","volume":"18","author":"Karami-Zarandi","year":"2023","journal-title":"Future Microbiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/jac\/dky107","article-title":"In vitro activity of imipenem\/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance program","volume":"73","author":"Karlowsky","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001487","article-title":"Activity of ceftolozane\/tazobactam against Gram-negative isolates among different infections in Hong Kong: SMART 2017-2019","volume":"71","author":"Karlowsky","year":"2022","journal-title":"J. Med. Microbiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/j.1469-0691.2008.02101.x","article-title":"New developments in carbapenems","volume":"14","author":"Kattan","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"B106","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2018.0438","article-title":"Effect of meropenem-vaborbactam vs piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the TANGO I randomized clinical trial","volume":"319","author":"Kaye","year":"2018","journal-title":"JAMA"},{"key":"B107","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1038\/s41467-020-19820-8","article-title":"The structural basis of promiscuity in small multidrug resistance transporters","volume":"11","author":"Kermani","year":"2020","journal-title":"Nat. Commun."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e02042","DOI":"10.1128\/AAC.02042-19","article-title":"Characterization\u00a0of FosL1, a plasmid-encoded fosfomycin resistance protein identified in Escherichia coli","volume":"64","author":"Kieffer","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009227","article-title":"A novel type of colistin resistance genes selected from random sequence space","volume":"17","author":"Knopp","year":"2021","journal-title":"PloS Genet."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043700","article-title":"Identification and analysis of the putative pentose sugar efflux transporters in Escherichia coli","volume":"7","author":"Koita","year":"2012","journal-title":"PloS One"},{"key":"B111","doi-asserted-by":"publisher","first-page":"403","DOI":"10.33073\/pjm-2019-048","article-title":"Antibiotic resistance among uropathogenic Escherichia coli","volume":"68","author":"Kot","year":"2019","journal-title":"Pol. J. Microbiol."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad287","article-title":"Multidrug resistance of Escherichia coli from outpatient uncomplicated urinary tract infections in a large United States integrated healthcare organization","volume":"10","author":"Ku","year":"2023","journal-title":"Open Forum Infect. Dis"},{"key":"B113","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13099-021-00431-7","article-title":"Presence of plasmid-mediated quinolone resistance (PMQR) genes in non-typhoidal Salmonella strains with reduced susceptibility to fluoroquinolones isolated from human salmonellosis in Gyeonggi-do, South Korea from 2016 to 2019","volume":"13","author":"Lee","year":"2021","journal-title":"Gut Pathog."},{"key":"B114","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0167-4781(98)00126-2","article-title":"DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities","volume":"1400","author":"Levine","year":"1998","journal-title":"Biochim. Biophys. Acta (BBA) - Gene Structure Expression."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2165\/11317030-000000000-00000","article-title":"Efflux-mediated drug resistance in bacteria: an update","volume":"69","author":"Li","year":"2009","journal-title":"Drugs"},{"key":"B116","doi-asserted-by":"publisher","first-page":"11680","DOI":"10.3390\/ijms241411680","article-title":"Bacterial biofilm formation on biomaterials and approaches to its treatment and prevention","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-biochem-062917-011942","article-title":"Ribosome-targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design","volume":"87","author":"Lin","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/antibiotics11101280","article-title":"Synergy between Mecillinam and Ceftazidime\/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae","volume":"11","author":"List","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"B119","doi-asserted-by":"publisher","first-page":"100518","DOI":"10.1016\/j.onehlt.2023.100518","article-title":"Using source-associated mobile genetic elements to identify zoonotic extraintestinal E. coli infections","volume":"16","author":"Liu","year":"2023","journal-title":"One Health"},{"key":"B120","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/jac\/dkx438","article-title":"Activity of ceftazidime\/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK 2015-16","volume":"73","author":"Livermore","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1099\/jmm.0.001142","article-title":"In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples\u2013SMART Surveillance Europe 2015\u20132017","volume":"69","author":"Lob","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1128\/AAC.00131-06","article-title":"The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics","volume":"50","author":"Long","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B123","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/antibiotics11030328","article-title":"Extraintestinal pathogenic Escherichia coli: beta-lactam antibiotic and heavy metal resistance","volume":"11","author":"Longhi","year":"2022","journal-title":"Antibiotics"},{"key":"B124","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jgar.2020.01.023","article-title":"Escherichia coli resistant to fosfomycin from urinary tract infections: detection of the fosA3 gene in Spain","volume":"21","author":"Loras","year":"2020","journal-title":"J. Global Antimicrobial Resistance."},{"key":"B125","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/antibiotics11050579","article-title":"New drugs\u00a0for the treatment of pseudomonas aeruginosa infections with limited treatment options: A narrative review","volume":"11","author":"Losito","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"B126","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1128\/JB.00756-13","article-title":"MacA, a periplasmic membrane fusion protein of the macrolide transporter MacAB-TolC, binds lipopolysaccharide core specifically and with high affinity","volume":"195","author":"Lu","year":"2013","journal-title":"J. Bacteriol."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02930-19","article-title":"Emergence of a plasmid-encoded resistance-nodulation-division efflux pump conferring resistance to multiple drugs, including tigecycline","volume":"11","author":"Lv","year":"2020","journal-title":"Klebsiella pneumoniae. mBio"},{"key":"B128","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.bcp.2005.10.021","article-title":"Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view","volume":"71","author":"Lynch","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10096-023-04576-y","article-title":"Genetic and enzymatic characterization of two novel bla(NDM-36, -37) variants in Escherichia coli strains","volume":"42","author":"Ma","year":"2023","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1906782","DOI":"10.1155\/2023\/1906782","article-title":"Gastrointestinal Infection in South African Children under the Age of 5 years: A Mini Review","volume":"2023","author":"Mafokwane","year":"2023","journal-title":"Gastroenterol. Res. Pract."},{"key":"B131","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1148603","article-title":"Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review","volume":"13","author":"Mahdizade Ari","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"705","DOI":"10.31838\/hiv23.01.119","article-title":"Investigation of the gene expression of class I integron and its relationship to antibiotic resistance in isolates of Escherichia coli causing urinary tract diseases","volume":"23","author":"Mahmood","year":"2023","journal-title":"HIV Nursing."},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01269-20","article-title":"In silico genotyping of Escherichia coli isolates for extraintestinal virulence genes by use of whole-genome sequencing data","volume":"58","author":"Malberg Tetzschner","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/ajhp\/zxab012","article-title":"Imipenem\/cilastatin\/relebactam: A new carbapenem \u03b2-lactamase inhibitor combination","volume":"78","author":"Mansour","year":"2021","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000541","article-title":"Interplay in the selection of fluoroquinolone resistance and bacterial fitness","volume":"5","author":"Marcusson","year":"2009","journal-title":"PloS Pathogens."},{"key":"B137","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/9781119593522.ch9","article-title":"Multidrug resistance","volume-title":"Bacterial Resistance to Antibiotics \u2013 From Molecules to Man","author":"Marshall","year":"2019"},{"key":"B138","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5812\/IJB.16833","article-title":"Molecular characterization and antimicrobial resistance of Uropathogenic Escherichia coli","volume":"12","author":"Mashayekhi","year":"2014","journal-title":"Iranian J. Biotechnol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"Masters","year":"2003","journal-title":"Arch. Internal Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/antibiotics10081012","article-title":"The revival of aztreonam in combination with avibactam against metallo-\u03b2-lactamase-producing gram-negatives: A systematic review of in vitro studies and clinical cases","volume":"10","author":"Mauri","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","article-title":"CRISPR-Cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance","volume":"9","author":"Mayorga-Ramos","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"B142","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/jac\/33.suppl_A.23","article-title":"Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens","author":"McOsker","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"B143","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/IJGM","article-title":"Urinary tract infections in women: etiology and treatment options","volume":"4","author":"Minardi","year":"2011","journal-title":"Int. J. Gen. Med."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1590\/S1517-83822012000400010","article-title":"Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from Brazil","volume":"43","author":"Minarini","year":"2012","journal-title":"Braz. J. Microbiol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jgar.2018.04.017","article-title":"Determination of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infection in Iran","volume":"13","author":"Mirzaii","year":"2018","journal-title":"J. Global Antimicrobial Resistance."},{"key":"B146","doi-asserted-by":"publisher","first-page":"8898430","DOI":"10.1155\/2020\/8898430","article-title":"Antibiotics profile, prevalence of extended-spectrum beta-lactamase (ESBL), and multidrug-resistant enterobacteriaceae from different clinical samples in Khartoum State, Sudan","volume":"2020","author":"Moglad","year":"2020","journal-title":"Int. J. Microbiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.3390\/foods12203726","article-title":"Pathogenic E. coli in the Food Chain across the Arab Countries: A Descriptive Review","volume":"12","author":"Mohamed","year":"2023","journal-title":"Foods"},{"key":"B148","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/lam.13619","article-title":"In vitro assessment of the antibacterial effects of the combinations of fosfomycin, colistin, trimethoprim and nitrofurantoin against multi-drug-resistant Escherichia coli","volume":"74","author":"Mohamed Abu El-Wafa","year":"2022","journal-title":"Lett. Appl. Microbiol."},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1035609","article-title":"Molecular mechanisms leading to ceftolozane\/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries","volume":"13","author":"Mojica","year":"2022","journal-title":"Front. Microbiol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1128\/AAC.45.12.3387-3392.2001","article-title":"Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA","volume":"45","author":"Montero","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B151","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jgar.2019.10.002","article-title":"Molecular epidemiology and nitrofurantoin resistance determinants of nitrofurantoin-non-susceptible Escherichia coli isolated from urinary tract infections","volume":"21","author":"Mottaghizadeh","year":"2020","journal-title":"J. Glob Antimicrob. Resist."},{"key":"B152","article-title":"Escherichia coli infection","volume-title":"StatPearls","author":"Mueller","year":"2023"},{"key":"B153","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s10096-019-03672-2","article-title":"Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli","volume":"38","author":"Mulder","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1128\/9781555819286","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"B155","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/mdr.2020.0432","article-title":"Phenotypic and genotypic characteristics of uropathogenic Escherichia coli isolates from Kenya","volume":"28","author":"Muriuki","year":"2022","journal-title":"Microb. Drug Resist."},{"key":"B156","doi-asserted-by":"publisher","first-page":"9520362","DOI":"10.1155\/2022\/9520362","article-title":"Genetic diversity, carbapenem resistance genes, and biofilm formation in UPEC isolated from patients with catheter-associated urinary tract infection in north of Iran","volume":"2022","author":"Nasrollahian","year":"2022","journal-title":"Int. J. Clin. Pract"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.737288","article-title":"Function and inhibitory mechanisms of multidrug efflux pumps","volume":"12","author":"Nishino","year":"2021","journal-title":"Front. Microbiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijantimicag.2018.12.004","article-title":"Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates","volume":"53","author":"Ostrer","year":"2019","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.str.2019.04.007","article-title":"Structural insights into the lipid A transport pathway in MsbA","volume":"27","author":"Padayatti","year":"2019","journal-title":"Structure"},{"key":"B160","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/antibiotics12010020","article-title":"Evaluation of antimicrobial resistance of different phylogroups of Escherichia coli isolates from feces of breeding and laying hens","volume":"12","author":"Pais","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"B161","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41396-022-01329-1","article-title":"Metabolic genes on conjugative plasmids are highly prevalent in Escherichia coli and can protect against antibiotic treatment","volume":"17","author":"Palomino","year":"2023","journal-title":"ISME J."},{"key":"B162","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/20477724.2018.1547542","article-title":"Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico","volume":"112","author":"Paniagua-Contreras","year":"2018","journal-title":"Pathog. Glob Health"},{"key":"B163","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1128\/AAC.02872-15","article-title":"Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model","volume":"60","author":"Pantel","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1080\/14656566.2019.1660772","article-title":"The latest advances in \u03b2-lactam\/\u03b2-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections","volume":"20","author":"Papp-Wallace","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"B165","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.02109","article-title":"Secondary effects of antibiotics on microbial biofilms","volume":"11","author":"Penesyan","year":"2020","journal-title":"Front. Microbiol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3949\/ccjm.80a.12182","article-title":"Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients","volume":"80","author":"Perez","year":"2013","journal-title":"Cleve Clin. J. Med."},{"key":"B168","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","article-title":"Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR","volume":"40","author":"P\u00e9rez-P\u00e9rez","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/antibiotics12030453","article-title":"In Vitro Activity of Ceftolozane-Tazobactam against Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa Obtained from Blood Cultures from Sentinel Public Hospitals in South Africa","volume":"12","author":"Perovic","year":"2023","journal-title":"Antibiotics"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","article-title":"Plasmid-determined AmpC-type beta-lactamases","volume":"46","author":"Philippon","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B171","doi-asserted-by":"publisher","first-page":"106228","DOI":"10.1016\/j.ijantimicag.2020.106228","article-title":"Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1Q119X mutants, and in vitro activity of cefepime\/taniborbactam against MBLs producing Enterobacterales","volume":"57","author":"Piccirilli","year":"2021","journal-title":"Int. J. Antimicrobial Agents."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22240","article-title":"Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterization: the AnTIC RCT","volume":"22","author":"Pickard","year":"2018","journal-title":"Health Technol. Assess"},{"key":"B173","doi-asserted-by":"publisher","first-page":"8907","DOI":"10.3390\/ijms23168907","article-title":"Prevalence of plasmid-mediated quinolone resistance (PMQRs) determinants and whole genome sequence screening of PMQR-producing E. coli isolated from men undergoing a transrectal prostate biopsy","volume":"23","author":"Piekarska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ARBA-0026-2017","article-title":"Antimicrobial resistance in Escherichia coli","volume":"6","author":"Poirel","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1473-3099(18)30554-1","article-title":"Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomized, double-blind, non-inferiority trial","volume":"18","author":"Portsmouth","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B176","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/jac\/dkz434","article-title":"Mutations that increase expression of the EmrAB-TolC efflux pump confer increased resistance to nitroxoline in Escherichia coli","volume":"75","author":"Pu\u00e9rtolas-Balint","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"B177","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/20477724.2021.2011578","article-title":"Clonal groups of extended-spectrum \u03b2-lactamase and biofilm producing uropathogenic Escherichia coli in Iran","volume":"116","author":"Qasemi","year":"2022","journal-title":"Pathog. Glob Health"},{"key":"B178","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.2147\/IDR.S363652","article-title":"Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Escherichia coli isolates from Ningbo, China","volume":"15","author":"Qian","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00138","article-title":"Escherichia coli O157:H7\u2014Clinical aspects and novel treatment approaches","volume":"2","author":"Rahal","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"4251486","DOI":"10.1155\/2022\/4251486","article-title":"Association of antibiotic resistance traits in uropathogenic Escherichia coli (UPEC) isolates","volume":"2022","author":"Rahman","year":"2022","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13099-017-0207-8","article-title":"Existence of a novel qepA variant in quinolone resistant Escherichia coli from aquatic habitats of Bangladesh","volume":"9","author":"Rahman","year":"2017","journal-title":"Gut Pathogens."},{"key":"B182","doi-asserted-by":"publisher","first-page":"636","DOI":"10.18502\/ijm.v14i5.10956","article-title":"Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens","volume":"14","author":"Raunak","year":"2022","journal-title":"Iranian J. Microbiol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4103\/0974-777X.68531","article-title":"Extended-spectrum \u03b2-lactamases in gram negative bacteria","volume":"2","author":"Rawat","year":"2010","journal-title":"J. Glob Infect. Dis."},{"key":"B184","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.phrp.2016.08.003","article-title":"Plasmid-mediated quinolone-resistance (qnr) genes in clinical isolates of Escherichia coli collected from several hospitals of Qazvin and Zanjan provinces, Iran","volume":"7","author":"Rezazadeh","year":"2016","journal-title":"Osong Public Health Res. Perspectives."},{"key":"B185","doi-asserted-by":"publisher","first-page":"105268","DOI":"10.1016\/j.ejps.2020.105268","article-title":"Exposure to sub-inhibitory ciprofloxacin and nitrofurantoin concentrations increases recA gene expression in uropathogenic Escherichia coli: The role of RecA protein as a drug target","volume":"146","author":"Ribeiro","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"B186","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/membranes12100981","article-title":"The role of outer membrane proteins in UPEC antimicrobial resistance: A systematic review","volume":"12","author":"Rodrigues","year":"2022","journal-title":"Membranes"},{"key":"B187","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/microorganisms10030611","article-title":"Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC","volume":"10","author":"Rodr\u00edguez-Guerrero","year":"2022","journal-title":"Microorganisms"},{"key":"B188","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/INF.0000000000003832","article-title":"Safety and efficacy of ceftolozane\/tazobactam versus meropenem in neonates and children with complicated urinary tract infection, including pyelonephritis: A phase 2, randomized clinical trial","volume":"42","author":"Roilides","year":"2023","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/genes13081397","article-title":"Molecular factors and mechanisms driving multidrug resistance in uropathogenic Escherichia coli-an update","volume":"13","author":"Rozwadowski","year":"2022","journal-title":"Genes (Basel)"},{"key":"B190","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/jac\/dkr548","article-title":"qnr, aac(6\u2032)-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location","volume":"67","author":"Ruiz","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B191","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1286-4579(03)00049-2","article-title":"Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem","volume":"5","author":"Russo","year":"2003","journal-title":"Microbes Infect."},{"key":"B192","doi-asserted-by":"publisher","first-page":"2850183","DOI":"10.1155\/2020\/2850183","article-title":"Characterization of Plasmid-Mediated Quinolone Resistance and Serogroup Distributions of Uropathogenic Escherichia coli among Iranian Kidney Transplant Patients","volume":"2020","author":"Sadeghi","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"B193","doi-asserted-by":"publisher","first-page":"100947","DOI":"10.1016\/j.nmni.2021.100947","article-title":"Prevalence of ESBL and AmpC genes in E. coli isolates from urinary tract infections in the north of Iran","volume":"45","author":"Sadeghi","year":"2022","journal-title":"New Microbes New Infect."},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000440","article-title":"Exploration into the origins and mobilization of di-hydrofolate reductase genes and the emergence of clinical resistance to trimethoprim","volume":"6","author":"S\u00e1nchez-Osuna","year":"2020","journal-title":"Microbial Genomics"},{"key":"B195","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0255-0857.148415","article-title":"YnfA , a SMR family efflux pump is abundant in Escherichia coli isolates from urinary infection","volume":"33","author":"Sarkar","year":"2015","journal-title":"Indian J. Med. Microbiol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/antibiotics9070397","article-title":"FimH and anti-adhesive therapeutics: A disarming strategy against uropathogens","volume":"9","author":"Sarshar","year":"2020","journal-title":"Antibiotics"},{"key":"B197","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/mdr.2013.0061","article-title":"First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan","volume":"19","author":"Sato","year":"2013","journal-title":"Microbial Drug Resistance."},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01917-17","article-title":"Point-counterpoint: piperacillin-tazobactam should be used to treat infections with extended-spectrum-beta-lactamase-positive organisms","volume":"56","author":"Schuetz","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12879-017-2502-x","article-title":"Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"17","author":"Seo","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/jac\/dks514","article-title":"Chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms among broad-spectrum-cephalosporin-resistant Escherichia coli isolates recovered from companion animals in the USA","volume":"68","author":"Shaheen","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B201","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.sjbs.2014.08.002","article-title":"Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment","volume":"22","author":"Shaikh","year":"2015","journal-title":"Saudi J. Biol. Sci."},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1025633","article-title":"The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic","volume":"10","author":"Shariati","year":"2022","journal-title":"Front. Public Health"},{"key":"B203","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/9781119593522.ch2","article-title":"Molecular mechanisms of antibiotic resistance \u2013 part II","volume-title":"Bacterial Resistance to Antibiotics \u2013 From Molecules to Man","author":"Sharkey","year":"2019"},{"key":"B204","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13756-019-0533-3","article-title":"Antibiotics versus biofilm: an emerging battleground in microbial communities","volume":"8","author":"Sharma","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.682205","article-title":"MgrB inactivation confers trimethoprim resistance in Escherichia coli","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Microbiol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/antibiotics12061061","article-title":"Antimicrobial resistance and clonal lineages of Escherichia coli from food-producing animals","volume":"12","author":"Silva","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B207","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1574-6976.2009.00198.x","article-title":"Broad-spectrum \u03b2-lactamases among Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on public health","volume":"34","author":"Smet","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"key":"B208","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1186\/1756-0500-7-842","article-title":"Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from Iranian hospital","volume":"7","author":"Soleimani","year":"2014","journal-title":"BMC Res. Notes."},{"key":"B209","doi-asserted-by":"publisher","first-page":"e00743","DOI":"10.1128\/Spectrum.00743-21","article-title":"Reducing the periplasmic glutathione content makes Escherichia coli resistant to trimethoprim and other antimicrobial drugs","volume":"9","author":"Song","year":"2021","journal-title":"Microbiol. Spectrum."},{"key":"B210","doi-asserted-by":"publisher","first-page":"31","DOI":"10.37201\/req","article-title":"Cefiderocol","author":"Soriano","year":"2022","journal-title":"Rev. Esp Quimioter."},{"key":"B211","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4161\/viru.23724","article-title":"Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm","volume":"4","author":"Soto","year":"2013","journal-title":"Virulence"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz360.2153","article-title":"2475. Incidence of multidrug-resistant, extensively drug-resistant and pandrug-resistant gram-negative bacteria in Brazilian intensive care units","volume":"6","author":"Souza","year":"2019","journal-title":"Open Forum Infect. Dis"},{"key":"B213","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41429-022-00537-3","article-title":"In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era","volume":"75","author":"Sreenivasan","year":"2022","journal-title":"J. Antibiotics."},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00709-20","article-title":"F plasmids are the major carriers of antibiotic resistance genes in human-associated commensal Escherichia coli","volume":"5","author":"Stephens","year":"2020","journal-title":"Msphere"},{"key":"B215","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/CMR.00016-09","article-title":"Plasmid-mediated quinolone resistance: a multifaceted threat","volume":"22","author":"Strahilevitz","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"B216","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.2147\/IDR.S357396","article-title":"Genetic diversity and in vitro activity of aztreonam\/avibactam and ceftazidime\/avibactam against carbapenem-resistant enterobacterales: A multi-center study in southwest China","volume":"15","author":"Sun","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s40265-021-01580-4","article-title":"Cefiderocol: A review in serious gram-negative bacterial infections","volume":"81","author":"Syed","year":"2021","journal-title":"Drugs"},{"key":"B218","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12941-023-00573-3","article-title":"Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope","volume":"22","author":"Taha","year":"2023","journal-title":"Ann. Clin. Microbiol. Antimicrobials."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/cid\/ciz173","article-title":"A primer on ampC \u03b2-lactamases: necessary knowledge for an increasingly multidrug-resistant world","volume":"69","author":"Tamma","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/jac\/dkq112","article-title":"Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli","volume":"65","author":"Tav\u00edo","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3390\/antibiotics10081023","article-title":"Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring bla(NDM-1) and bla(NDM-5)","volume":"10","author":"Terbtothakun","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"B222","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1146\/annurev-biochem-011520-105201","article-title":"Structural and mechanistic principles of ABC transporters","volume":"89","author":"Thomas","year":"2020","journal-title":"Annu. Rev. Biochem."},{"key":"B223","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.2147\/IDR.S337611","article-title":"Emerging carbapenem-resistant enterobacteriaceae infection, its epidemiology and novel treatment options: A review","volume":"14","author":"Tilahun","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"B224","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","article-title":"\u03b2-lactamases and \u03b2-lactamase inhibitors in the 21st century","volume":"431","author":"Tooke","year":"2019","journal-title":"J. Mol. Biol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"106574","DOI":"10.1016\/j.ijantimicag.2022.106574","article-title":"Susceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study","volume":"59","author":"Tutone","year":"2022","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.20","article-title":"Growth and maintenance of Escherichia coli laboratory strains","volume":"1","author":"Tuttle","year":"2021","journal-title":"Curr. Protoc."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/antibiotics11081079","article-title":"Antibiotic resistance in bacteria-A review","volume":"11","author":"Urban-Chmiel","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"B228","doi-asserted-by":"publisher","first-page":"105315","DOI":"10.1016\/j.idairyj.2021.105315","article-title":"Investigation of major carbapenemase genes in ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from raw milk in Black Sea region of Turkey","volume":"128","author":"Uyanik","year":"2022","journal-title":"Int. Dairy J."},{"key":"B229","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1128\/AAC.01834-09","article-title":"Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes","volume":"54","author":"Wachino","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B230","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3390\/antibiotics11121821","article-title":"Current and emerging treatment options for multidrug resistant Escherichia coli urosepsis: A review","volume":"11","author":"Walker","year":"2022","journal-title":"Antibiotics"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000702","article-title":"Alterations in chromosomal genes nfsA, nfsB, and ribE are associated with nitrofurantoin resistance in Escherichia coli from the United Kingdom","volume":"7","author":"Wan","year":"2021","journal-title":"Microb. Genom"},{"key":"B232","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3390\/microorganisms11092169","article-title":"Uropathogenic Escherichia coli (UPEC)-associated urinary tract infections: the molecular basis for challenges to effective treatment","volume":"11","author":"Whelan","year":"2023","journal-title":"Microorganisms"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000197","article-title":"Extended-spectrum \u03b2-lactamase-producing and carbapenemase-producing enterobacteriaceae","volume":"4","author":"Wilson","year":"2018","journal-title":"Microb. Genom"},{"key":"B234","doi-asserted-by":"publisher","first-page":"e00115","DOI":"10.1128\/CMR.00115-20","article-title":"New \u03b2-lactam-\u03b2-lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"B235","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jmii.2021.02.001","article-title":"Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan","volume":"55","author":"Yang","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B236","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1126\/science.1125629","article-title":"Structure of the multidrug transporter EmrD from Escherichia coli","volume":"312","author":"Yin","year":"2006","journal-title":"Science"},{"key":"B237","doi-asserted-by":"publisher","first-page":"183488","DOI":"10.1016\/j.bbamem.2020.183488","article-title":"Structural characterization of the EmrAB-TolC efflux complex from E. coli","volume":"1863","author":"Yousefian","year":"2021","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"B238","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/microorganisms9040799","article-title":"Genomic Insights into a\u00a0Colistin-Resistant Uropathogenic Escherichia coli Strain of O23:H4-ST641 Lineage\u00a0Harboring mcr-1.1 on a Conjugative IncHI2 Plasmid from Egypt","volume":"9","author":"Zakaria","year":"2021","journal-title":"Microorganisms"},{"key":"B239","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12941-021-00457-4","article-title":"Virulence characterization and clonal analysis of uropathogenic Escherichia coli metallo-beta-lactamase-producing isolates","volume":"20","author":"Zangane Matin","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrobials."},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.653983","article-title":"Antimicrobial resistance and molecular epidemiology of uropathogenic Escherichia coli isolated from female patients in Shanghai, China","volume":"11","author":"Zeng","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40265-017-0851-9","article-title":"Imipenem-relebactam and meropenem-vaborbactam: two novel carbapenem-\u03b2-lactamase inhibitor combinations","volume":"78","author":"Zhanel","year":"2018","journal-title":"Drugs"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1093842","article-title":"Efficacy and safety of piperacillin\u2013tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"104196","DOI":"10.1016\/j.micpath.2020.104196","article-title":"A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections","volume":"144","author":"Zhao","year":"2020","journal-title":"Microb. Pathog."},{"key":"B244","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1128\/JCM.02594-14","article-title":"Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals","volume":"53","author":"Zhao","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03349-22","article-title":"A novel CMY variant confers transferable high-level resistance to ceftazidime-avibactam in multidrug-resistant Escherichia coli","volume":"11","author":"Zhou","year":"2023","journal-title":"Microbiol. Spectr."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1387497\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T07:40:58Z","timestamp":1712216458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1387497\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":245,"alternative-id":["10.3389\/fcimb.2024.1387497"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1387497","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,4]]},"article-number":"1387497"}}